Can baby hearts regrow? scientists seek answers in tiny tissue samples

NCT ID NCT06587165

Recruiting now Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to measure how well infants' hearts can make new muscle cells, especially in those with a heart condition called Tetralogy of Fallot. Researchers will use a special imaging technique on heart tissue that is normally removed and thrown away during surgery. The goal is to learn more about heart regeneration, not to provide a new treatment. About 30 infants under 1 year old will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure tetralogy of fallot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE TETRALOGY OF FALLOT WITH PULMONARY STENOSIS

Contacts and locations

Locations

Children's Hospital of Philadelphia
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Columbia University (Morgan Stanley Children's Hospital)
NOT_YET_RECRUITING

New York, New York, 10032, United States
Upmc Children'S Hospital of Pittsburgh
NOT_YET_RECRUITING

Pittsburgh, Pennsylvania, 15224, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.